Haemonetics Pre-Announces 2nd Quarter Results, Revises Fiscal Year 2016 Guidance and Sets Date for 2nd Quarter Earnings Release: November 4, 2015
While the first half was in line with expectations, the Company has revised its previously-issued revenue and adjusted earnings guidance for the full fiscal year 2016. Revenue is now expected to be within the range of
The Company indicated that the shortfall in second half revenue is attributable principally to continuing deterioration in the market for its products in
The Company will report its results for the second quarter of fiscal year 2016 on
Webcast Link: http://www.media-server.com/m/acs/e58732b94af2a8968146003700d7c56c
Webcast replay will be available from
ABOUT
FORWARD LOOKING STATEMENTS
This release contains forward-looking statements that involve risks and uncertainties, including the effects of disruption from the manufacturing transformation making it more difficult to maintain relationships with employees and timely deliver high quality products, unexpected expenses incurred during our Value Creation and Capture program, asset revaluations to reflect current business conditions, technological advances in the medical field and standards for transfusion medicine and our ability to successfully commercialize products that incorporate such advances and standards, customer acceptance of new products, demand for whole blood and blood components, product quality, market acceptance, regulatory uncertainties, including in the receipt or timing of regulatory approvals, the effect of economic and political conditions, the impact of competitive products and pricing, blood product reimbursement policies and practices, foreign currency exchange rates, changes in customers' ordering patterns including single-source tenders, the effect of industry consolidation as seen in the plasma and blood center markets, the effect of communicable diseases and the effect of uncertainties in markets outside the U.S. (including
The foregoing list should not be construed as exhaustive.
Forward-looking statements are based on estimates and assumptions made by management of the Company and are believed to be reasonable, though inherently uncertain and difficult to predict. Actual results and experience could differ materially from the forward-looking statements. Information set forth in this press release is current as of today and the Company undertakes no duty or obligation to update this information.
1 A reconciliation of GAAP to adjusted financial results will be included at the end of the financial sections of the Company's full earnings press release on
CONTACT:
Tel. (781) 356-9402
gerry.gould@haemonetics.com
Logo - http://photos.prnewswire.com/prnh/20150128/172006LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-pre-announces-2nd-quarter-results-revises-fiscal-year-2016-guidance-and-sets-date-for-2nd-quarter-earnings-release-november-4-2015-300154370.html
SOURCE